- 1.
Murray CJL, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436 – 42.
- 2.
Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990 – 2020: Global Burden of Disease Study. Lancet 1997; 349: 1498 – 504.
- 3.
Sartorius N. Foreword on ”Economics of anxiety and depression”. Brit J Psychiatry 1995; 166 (suppl 27): 6.
- 4.
Diagnostic and statistical manual of mental disorders: DSM-IV. 4. utg. Washington, D.C.: American Psychiatric Association, 1994.
- 5.
Tsuang MT, Tohen M, Zahner GEP. Textbook in psychatric epidemiology. New York: Wiley-Liss, 1995.
- 6.
Kaelber CT, Moul DE, Farmer ME. Epidemiology of depression. I: Beckham EE, Leber WR, red. Handbook of depression. 2. utg. New York: Guilford Press, 1995: 3 – 35.
- 7.
Lépine J-P, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharm 1997; 12: 19 – 29.
- 8.
Rupp A. The economic consequences of not treating depression. Brit J Psychiatry 1995; 166 (suppl 27): 29 – 33.
- 9.
Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry 1990; 54: 405 – 18.
- 10.
Knapp M, Henderson J. Health economics perspectives and evaluation of child and adolescent mental health services. Curr Opin Psychiatry 1999; 12: 393 – 7.
- 11.
Kessler RC, Foster CL, Saunders WB, Stang PE. Social consequences of psychiatric disorders, I: Educational attainment. Am J Psychiatry 1995; 152: 1026 – 32.
- 12.
Rupp A, Gause EM, Regier DA. Research policy implications of cost-of-illness studies for mental disorders. Brit J Psychiatry 1998; 173 (suppl 36): 19 – 25.
- 13.
Rice DP, Miller LS. The economic burden of affective disorders. Brit J Psychiatry 1995; 166 (suppl 27): 34 – 42.
- 14.
Greenberg PE, Kessler RC, Nells TL, Finkelstein SN, Berndt ER. Depression in the workplace: An economic perspective. I: Feighner JP, Boyer WF, red. Selective serotonin re-uptake inhibitors. 2. utg. Chichester: John Wiley & Sons, 1996.
- 15.
Kessler RN, Frank RG. The impact of psychiatric disorders on work loss days. Psychol Med 1997; 27: 861 – 73.
- 16.
Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. J Am Med Assoc 1992; 267: 1478 – 83.
- 17.
Conti DJ, Burton WN. The economic impact of depression in a workplace. J Occup Med 1994; 36: 983 – 8.
- 18.
Tylee A, Gastpar M, Lépine J-P, Mendlewicz J. DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. Int Clin Psychopharm 1999; 14: 139 – 51.
- 19.
Harris EC, Barraclough B. Excess mortality of mental disorder. Brit J Psychiatry 1998; 173: 11 – 53.
- 20.
Hirschfeld RMA, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F et al. The National Depressive and Manic-Depressive Association Consensus Statement on the Undertreatment of Depression. J Am Med Assoc 1997; 277: 333 – 40.
- 21.
Pincus HA, Davis WW, McQueen LE. ”Subtreshold” mental disorders. A review and synthesis of studies on minor depression and other ”brand names”. Brit J Psychiatry 1999; 174: 288 – 96.
- 22.
Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiological survey. J Am Med Assoc 1990; 264: 2524 – 8.
- 23.
Wittchen H-U. Critical issues in the evaluation of comorbidity of psychiatric disorders. Brit J Psychiatry 1996; 168 (suppl 30): 9 – 16.
- 24.
Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JRT et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999; 60: 427 – 35.
- 25.
Tylee A, Gastpar M, Lépine J-P, Mendlewicz J. Identification of depressed patient types in the community and their treatment needs: findings from the DEPRES II (Depression Research in European Society II) Survey. Int Clin Psychopharm 1999; 14: 153 – 65.
- 26.
Katz PP, Yelin EH. Prevalence and correlates of depressive symptoms among persons with rheumatoid-arthritis. J Rheumatol 1993; 20: 790 – 6.
- 27.
Whooley MA. Depression and medical illness. Ann Epidemiol 1999; 9: 281 – 2.
- 28.
Jönsson B, Rosenbaum J. Health Economics of Depression. Chichester, England: John Wiley & Sons, 1993.
- 29.
Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry 1998; 155: 4 – 11.
- 30.
Wells KB, Stewart A, Hays RD, Burnam A, Rogers W, Daniels M et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. J Am Med Assoc 1989; 262: 914 – 9.
- 31.
Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992; 49: 761 – 8.
- 32.
Rapaport MH, Judd LL. Minor depressive disorder and subsyndromal depressive symptoms: functional impairment and response to treatment. J Affect Disord 1998; 48: 227 – 32.
- 33.
Moscarelli M. Introduction to ”Economics of anxiety and depression”. Brit J Psychiatry 1995; 166 (suppl 27): 7 – 9.
- 34.
Rosholm J-U. Antidepressants in general practice. Doktoravhandling. Odense: Odense university, 1994.
- 35.
Regier DA, Hirschfeld RMA, Goodwin FK, Burke JD, Lazar JB, Judd LL. The NIMH Depression Awareness, Recognition, and Treatment Program: structure, aims, and scientific basis. Am J Psychiatry 1988; 145: 1351 – 7.
- 36.
Wells KB, Sturm R, Sherbourne CD, Meredith LS. Caring for depression. Cambridge, Massachusetts: Harvard University Press, 1996.
- 37.
Rix S, Paykel ES, Lelliott P, Tylee A, Freeling P, Gask L et al. Impact of national campaign on GP education: an evaluation of the Defeat Depression Campaign. Brit J Gen Pract 1999; 49: 99 – 102.
- 38.
Rutz W, Wålinder J, Pihlgren H, Knorring Lv, Rihmer Z. Lessons from the Gotland Study on depression, suicide and education: Effects, shortcomings and challenges. Int J Method Psych 1996; 6: S9-S14.
- 39.
Thompson C, Stevens L, Ostler K, Cooper D, Preece J, Henson A et al. The Hampshire Depression Project: a methodology for assessing the value of general practice education in depression. Int J Method Psych 1996; 6: S27 – 31.
- 40.
Thompson C, Kinmonth AL, Stevens L, Peveler RC, Stevens A, Ostler KJ et al. Effects of a clinical-practice guideline and practice-based education on detection and outcome of depression in primary care: Hampshire Depression Project randomised controlled trial. Lancet 2000; 355: 185 – 91.
- 41.
Lloyd K, Jenkins R. The economics of depression in primary care. Brit J Psychiatry 1995; 166 (suppl 27): 60 – 2.
- 42.
Norges forskningsråd. Behandling av depresjon i allmennpraksis. Konsensuskonferanse. Rapport nr. 14 fra komiteen for konsensuskonferanseprogrammet. Oslo: Norges forskningsråd, 1999.
- 43.
Dowrick C, Casey P, Dalgard O, Hosman C, Lehtinen V, Vâzquez-Barquero J-L et al. Outcomes of Depression International Network (ODIN). Background, methods and field trials. Brit J Psychiatry 1998; 172: 359 – 63.
- 44.
Kind P, Sorensen J. The costs of depression. Int Clin Psychopharm 1993; 7: 191 – 5.
- 45.
Hensing G, Spak F. Psychiatric disorders as a factor in sick-leave due to other diagnoses. Brit J Psychiatry 1998; 172: 250 – 6.
- 46.
Chevalier A, Bonenfant S, Picot M-C, Chastang J-F, Luce D. Occupational factors of anxiety and depressive disorders in the French National Electricity and Gas Company. J Occup Environ Med 1996; 38: 1098 – 1107.
()
Denne artikkelen ble publisert for mer enn 12 måneder siden, og vi har derfor stengt for nye kommentarer.